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Report on the Tenth Colloquium of the Postgraduate Forum on 




The Postgraduate Forum on Genetics and Society (PFGS) is a fluid group of doctoral 
(and other) researchers, organised and run by those same researchers on a voluntary 
basis, which is committed to providing a collegial and supportive environment for 
collaboration and skills training. 
 
While the PFGS is an active online community1 in which information and news can 
be discussed and exchanged, its members also meet regularly to discuss and present 
their ongoing research, as well as participate in workshops. From 30 of August until 1 
September 2006, postgraduate researchers working in and around areas of genetics 
and society met for the tenth time since the inception of their network in 1998. 
 
Despite the fact that these colloquia have traditionally been held in the UK, PFGS has 
members the Netherlands, Austria, Finland, Australia, USA, Denmark, Germany, 
Romania, Tasmania, and India. Five nations were represented at the tenth meeting, 
held at the University of York. Disciplinary backgrounds also vary, from sociology to 
biology, law, philosophy, science and technology studies and theatre; the PFGS 
believes strongly that issues surrounding genetics and society necessitate a 
multiplicity of perspectives if the subject matter is to be dealt with fairly, and if 
learning in these areas is to flourish. 
 
Rather than attempt to summarise the thirty-odd papers that were presented over the 
three days,2 this report will consist of a reflection on the theme of the event: 
‘Implications and implementation - the meaning and use of our research.’ 
 
Since joining the network in 2005, I have noticed a profound interest among members 
in the utility or impact of their research. Some members doubt whether the wider 
community of genetics related researchers will be receptive to their work, while others 
question the notions of ‘impact’ or ‘utility’ and problematise the merits of these goals 
when it comes to doctoral research. Still others are seeking applications for their 
research findings. 
 
Irrespective of their individual positions on these matters, the thirty-plus PhD students 
attending the colloquium were invited to address these issues head-on by way of a 
series of ‘implementation workshops.’ 
 
The goals and the realities of ‘implementation workshops’ 
 
Our original vision for these workshops was to team-up various ‘users’ of genetic 
information with PFGS members so that a connection could be made between the 
research that PFGS members are doing and genetic practices ‘out there’. The hope 
was that our research and our skills might apply to their work in practice and, 
conversely, that their experiences with the various elements of genetics might inform 
our own work. 
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The fact of the matter is that postgraduate research does not take place within an 
experiential vacuum. Arguably, this is particularly true of research in areas of genetics 
and society. This is because (postgraduate) research in this area often employs 
ethnographic research techniques, which can mean that for weeks on end we find 
ourselves shoulder to shoulder with lab scientists as they isolate strands of DNA or 
stem cells lines. During this process we evolve from being laboratory fixtures that are 
useful for making coffee, and become lab assistants, friends and confidants of the 
scientists in question. 
 
In other doctoral research scenarios PFGS, members are engaged with in-depth 
qualitative research with end-users of genetic sciences (eg, patients or medical 
practitioners). In these situations we are not simply ‘in the field collecting data,’ but 
are interacting with real people who have lives and stories. Data cannot, therefore, be 
harvested as if they were a crop. Indeed, frequently, such research leads us to become 
a part of their stories. 
 
As a result, PFGS members can find themselves in situation in which they are not 
simply observing the processes by which the content of science is created or 
consumed; rather, often we can find ourselves knee-deep in the production process 
itself or in the difficult position of mediating how this knowledge is internalised. 
 
This level of engagement in genetics suggests that PFGS researchers (among others) 
are in a position to make a valuable contribution to the areas that they study. The four 
implementation workshops were intended to highlight these contributions to the 
workshop leaders - people who regularly use various kinds of genetic information. 
 
Leaders of the implementation workshops 
 
Dr Angela Flannery, director within R&D genetics at AstraZenica 
In a very engaging presentation Dr. Flannery ‘tested’ PFGS members as to their 
knowledge that genetics plays in the drug development pipeline. Suitably impressed 
with our level of knowledge of the subject matter, Dr. Flannery spoke of how ‘big 
pharma’ does indeed see a use for the kinds of research being conducted by members 
of the PFGS. For instance, she mentioned the need for industry to have a firmer 
handle on shifting licensing, ethical and regulatory procedures, as well as public 
engagement activities about genetic testing and levels of acceptance of genetics in 
drugs among patients. 
 
Dr Helen Middleton-Price, director of the North West Genetics Knowledge Park 
(NOWGEN) 
Dr. Middleton-Price first gave an overview of aims and activities within the North 
West Genetics Knowledge Park. This was followed by a discussion about “the usual 
misunderstandings” and challenges of working in an interdisciplinary environment. 
For example, many bioscientists and medical professionals feel that the contribution 
of social scientists to their work is limited to helping out with ethical approval forms, 
while social scientists in turn feel they have a monopoly on studying issues to do with 
socio-economic aspects of innovative health technologies and access to patient care 
and treatment. 
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Miss. Pam Davies, family services manager at the patient advocacy group CLIMB 
Miss. Davies discussed the role of ‘information provision’ that CLIMB plays for 
families with children with rare chromosomal disorders. She also detailed its role in 
funding research into these disorders. Discussion centred on the role CLIMB played 
in pseudo-diagnosing children who came into contact with their organisation, and the 
professional implications that pseudo-diagnosis and information provision has for the 
medical community. 
 
Mrs. Tara Clancy, consultant genetic counsellor and lecturer in medical genetics, St. 
Mary’s Hospital, Manchester 
This interactive session stimulated discussion between attendees and Mrs. Clancy 
regarding the differences between what genetic counsellors do in theory, and what 
actually happens in practice. Along these lines, conditions and contexts in which 
counselling takes place were discussed and attendees were able to scope future areas 
that may pose new or different ethical issues. The discussion concluded with critical 
reflection on the ability of biomedical ethics to deal with socio-political issues that 
advances in biosciences are now beginning to pose. 
 
The problem of ‘implementation’ 
 
Our original vision for these implementation workshops - to promote dialogue about 
the use of genetic information between doctoral researchers and actors outside of 
academia - may have been overly ambitious for an afternoon of meetings. In 
retrospect, without the workshop leaders doing a lot of background reading on the 
subject of our dissertations, and without the doctoral researchers familiarising 
themselves with the role and function of these ‘users’ of genetic information, such 
links would be difficult to achieve in the 90 minute workshops. Nevertheless, these 
were extremely interesting sessions. PFGS members certainly benefited from the 
discussions about how genetic information is used in practice, and I believe that new 
ideas and avenues of research were spawned during these sessions. After 
presentations from the ‘users’ of genetic information, I feel that PFGS members were 
able to identify where their research could apply in practice. Perhaps similar 
presentations from PFGS members about their own research would have fostered 
further collaboration, in that the ‘users’ could then see for themselves where our work 
could fit into their practices. 
 
Would presentations be enough to foster collaboration and lead to the implementation 
of our work? Is this implementation the goal of PhD research? If the York workshops 
did not lead to direct collaboration, they certainly provided a platform for reflection 
on questions such as these. 
 
After these workshops, informal discussion centred on the notion of change (ie, the 
consequence of implementation) and how this notion can be much more nuanced and 
subtle than the traditional ‘cause and effect’ framework that is applied in much of the 
science we study. Can doctoral students expect to see direct results from our research 
efforts, even if we are lucky enough to make collaborative links with users of genetic 
information outside of academia? If so, what might those results look like? What form 
would they take? How would we be able to judge or assess the relative impacts of 
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these results? All of these questions highlight the complexities faced by the doctoral 
students at the York meeting. 
 
Practical problems associated with interdisciplinary research were also raised. Can 
implementation take place when professional and disciplinary boundaries are 
constantly being reproduced and defended by those we are attempting to work with? 
Such questions were not directed at the leaders of the workshops, but simply reflected 
the issue of power and complexity in knowledge production and dissemination. 
Members certainly felt that there was great value and potential in working across 
disciplinary and professional boundaries. If we could collectively get as far as 
learning (that is two-way learning…we learn from them and they learn from us), then 
that would represent a great start.  
 
Closing remarks: the importance of postgraduate research and its 
implementation 
 
What will be the result of years of research and writing that is represented in our 
theses? 
 
What are the possible areas in which it might make an impact? 
 
How can our research be informed by differing applications of genetic information in 
practices? 
 
What are examples of genetics in practice, and how might our research make in 
impact in those areas? 
 
Irrespective of the relative success or failure of the implementation workshops, I 
would maintain that the questions above are (or dare I say “should be”) central 
concerns for doctoral research being undertaken in the arena of genetics and society. 
The issues examined by PFGS members (along with other doctoral research) are 
simply too important to be left in academic ivory towers, and we spend simply too 
much time on the work to let it evaporate into obscurity. 
 
It is not simply the effort that is invested in these projects undertaken by PFGS 
members that makes them important, however; they also have the potential to add real 
value to the production of genetic sciences. As we stand shoulder to shoulder with 
laboratory researchers, or share a cup of tea with a patient with a genetic disorder, we 
straddle the boundary between the often very different worlds of science and society. 
By doing so we are in a rare position to create links between the knowledge 
production process and its subsequent applications. Furthermore, while we are lucky 
enough to have access rights to these knowledge production and consumption 
processes, I feel that we have a concurrent responsibility to bring a certain amount of 
reflexive engagement to both of these activities. The production and consumption of 
genetic sciences are not passive activities. The degree to which co-production 
processes are at work perhaps even call into question such linear terms as ‘production’ 
and ‘consumption’. Pains must be taken to make this clear when implementation is 
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sought, and we should not be satisfied with a hope that the messages and value within 
doctoral research falls on sympathetic ears. 
 
Clearly, there are challenges to linking up academic work with day-to-day practices in 
genetics. Perhaps this is true of doctoral research in particular as we often lack the 
institutional longevity, publication record, or network associations of other academics. 
Nevertheless, with some of the challenges of implementation now on the radar for the 
PFGS surely we are in a better position to open up productive dialogues between 
these disparate actors working in related areas. 
 
In some research careers, the opportunity to delve as deeply into a substantive area as 
by doctoral work permits rarely presents itself again. Seldom does a research topic get 
such focused and undivided attention as when a PhD project is applied to it. These 
projects represent a great opportunity, not only for the researcher but also for 
potentially positive change to the associated area of inquiry. It would be a shame to 
see these opportunities misspent. Recognition of the value of doctoral researcher is 
required, but at the same time onus also rests on those doctoral researchers to step 
outside of their comfort zone and do something with their work. This represents a 




The PFGS warmly thank the ESRC Genomic Policy and Research Forum for its 
support of our network for the third consecutive year. We also thank the ESRC 
Innovative Health Technologies Programme for its support in 2006 as well as in 2002. 
 
 
                                                          
1 The PFGS manages a website at http://pfgs.org/ and a bulletin board at 
http://pfgs.org/phpBB/index.php. The website contains information on previous colloquia, a newsletter, 
a peer-review journal, and details of upcoming events including our own regional meetings and 
workshops. The bulletin board is a site for direct discussion of issues of interest to researchers working 
in the field of genetics and society. To become a member of the PFGS please visit the website or 
contact the author of this paper. Membership is free. 
2 Abstracts of papers, the colloquium programme and more can be viewed at 
http://pfgs.org/mambo/index.php?option=com_content&task=category&sectionid=7&id=46&Itemid=4
9. Sessions included: public understanding and participation of genetics; international governance in 
bioscience; DNA sequencing and standardization; genetic privacy & law; tissues & issues; negotiation 
and expectation in bioscience; implementing genetics into clinical practice; and the future of science & 
biocapital. 
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